政大機構典藏-National Chengchi University Institutional Repository(NCCUR):Item 140.119/38445
English  |  正體中文  |  简体中文  |  Post-Print筆數 : 27 |  Items with full text/Total items : 113311/144292 (79%)
Visitors : 50930506      Online Users : 967
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version
    政大典藏 > College of Commerce > International MBA > Theses >  Item 140.119/38445


    Please use this identifier to cite or link to this item: https://nccur.lib.nccu.edu.tw/handle/140.119/38445


    Title: 生技製藥產業併購策略─羅氏集團與基因科技公司個案研究
    Strategic merger & acquisition in bio-pharmaceutical industry-Roche and genentech case study
    Authors: 陳潔萱
    Chen, Sarah
    Contributors: 何小台
    Ho, Chester
    陳潔萱
    Chen, Sarah
    Keywords: 生技製藥
    Date: 2009
    Issue Date: 2010-06-15 16:24:56 (UTC+8)
    Abstract: 生技製藥產業併購策略
    The biotechnology companies started with the development of genetic engineering and antibody production in the U.S. and until today U.S. is still the leader in this industry. In recent years, they are becoming particular interest to established pharmaceutical companies. This thesis will first introduce the characteristic of pharmaceutical industry and its current situations, Next to explain pharmaceutical company’s unique relationship with biotechnology by studying the merger and acquisition case of Roche and Genentech. With the results, we will have better understanding of the business challenge and strategy for the industry.
    International MBA Program i
    College of Commerce i
    National Chengchi University i
    A Thesis i
    1. Introduction 1
    1.1. Research Background and Motive 1
    1.2. Research Objective 2
    2. Motivation for Merger and Acquisition 3
    2.1. Value Creation Theory 3
    2.2. The Synergy Creation Theory 3
    2.3. The Disciplinary Takeover Theory 4
    3. Company Background 5
    3.1. The Roche Group 5
    3.1.1. History and Background 5
    3.1.2. Company Structure 6
    3.1.3. Financial Result 8
    3.1.4. Product and Services 9
    3.1.5. Corporate Strategy 10
    3.2. The Genentech Group 11
    3.2.1. History and Background 11
    3.2.2. Company Structure 11
    3.2.3. Financial Result 12
    3.2.4. Product and Services 13
    3.2.5. Corporate Strategy 14
    4. Industry Analysis 16
    4.1. Industry Overview 16
    4.2. Industry Risk 17
    4.2.1. Research & Development Risk 18
    4.2.2. Risk of Substitute Products 22
    4.2.3. Regulation Risk 25
    4.2.4. Product Promotion Risk 26
    4.3. Industry Trend 27
    4.3.1. Cost Saving 27
    4.3.2. More Mergers and Acquisition to Come 28
    4.3.3. Personalized HealthCare 31
    5. Merger Transaction Case Analysis 32
    5.1. Brief History of the First Acquisition in 1990 32
    5.2. Roche Offer to Acquire all Outstanding Shares of Genentech 34
    5.3. The Challenge Ahead 37
    5.3.1. Keeping the Genentech Culture 37
    5.3.2. The New Structure 38
    5.3.3. Why Now 39
    5.3.4. Financial Value Drivers 40
    6. Summary and Conclusion 42
    Reference: 1. Decker, Susan. "Pfizer Wins New Lipitor Patent Expiring in June 2011 (Update2) ". Bloomberg.com. January 6, 2010 <http://www.bloomberg.com>
    2. Gassmann, Oliver, Gerrit Reepmeyer, and Maximilian von Zedtwitz. Leading Pharmaceutical Innovation. Berlin Heidelberg: Springer-Verlag, 2008.
    3. Grabowski, H.; Vernon, J.; DiMasi, J. “Returns on Research and Development for 1990s New Drug Introductions.” Pharmacoeconomics 20, Dec. 2002: 11-29.
    4. Saftlas, Herman. "Industry Surveys Healthcare: Pharmaceuticals". Standard & Poor`s November 27, 2008: 1-38.
    5. Roche Financial Report 2008. Basel, Switzerland: F. Hoffmann-La Roche Ltd., 2009.
    6. We are Genentech 2008 Annual Report. South San Francisco, CA: Genentech Inc., 2009.
    7. "Company Portrait". Roche Global Web Site. December 24, 2009 <http://www.roche.com/about_roche/at_a_glance/company_portrait.htm>.
    8. "Company Structure". Roche Global Web Site. December 24, 2009 <http://www.roche.com/about_roche/at_a_glance/company_structure.htm>.
    9. "Pharmaceutical R&D". Roche Global Web Site. December 24, 2009 <http://www.roche.com/research_and_development/r_d_overview/pharmaceuticals.htm>.
    10. "Corporate Overview Home". Genentech official website. December 24, 2009 <http://www.gene.com/gene/about/corporate/>.
    11. "Research Focus Areas". Genentech official website. December 24, 2009 <http://www.gene.com/gene/research/focusareas/>.
    12. Huckman, Mike. "Roche-Genentech: As The Deal Turns ". CNBC. January 9, 2010 <http://www.cnbc.com>.
    13. Morrill, David. "Roche, Genentech now one". ContraCostaTimes. January 6, 2009 <http://www.contracostatimes.com/business>
    14. “Pharmaceutical Research and Manufacturers of America (PhRMA)”, 2007 R&D Report: The pursuit of High Performance through Research and Development, Dec. 26 2009, http://www.phrma.org
    15. Pollack, Andrew. "Genentech-Roche Deal May Spur Similar Ties". The New York Times. January 6, 2010 <http://www.nytimes.com/pages/business/index.html>.
    16. "Roche Initiates Hostile Takeover Bid for Genentech at US$86.5 per Share". Global Insight. January 9, 2010 <http://www.ihsglobalinsight.com/>
    17. Schmit, Julie. "Genentech shares surge on Roche`s $44 billion offer". USA Today. January 6, 2010 <http://www.usatoday.com/money/industries/health>.
    Description: 碩士
    國立政治大學
    國際經營管理碩士班(IMBA)
    95933007
    98
    Source URI: http://thesis.lib.nccu.edu.tw/record/#G0959330071
    Data Type: thesis
    Appears in Collections:[International MBA] Theses

    Files in This Item:

    File SizeFormat
    index.html0KbHTML2537View/Open


    All items in 政大典藏 are protected by copyright, with all rights reserved.


    社群 sharing

    著作權政策宣告 Copyright Announcement
    1.本網站之數位內容為國立政治大學所收錄之機構典藏，無償提供學術研究與公眾教育等公益性使用，惟仍請適度，合理使用本網站之內容，以尊重著作權人之權益。商業上之利用，則請先取得著作權人之授權。
    The digital content of this website is part of National Chengchi University Institutional Repository. It provides free access to academic research and public education for non-commercial use. Please utilize it in a proper and reasonable manner and respect the rights of copyright owners. For commercial use, please obtain authorization from the copyright owner in advance.

    2.本網站之製作，已盡力防止侵害著作權人之權益，如仍發現本網站之數位內容有侵害著作權人權益情事者，請權利人通知本網站維護人員(nccur@nccu.edu.tw)，維護人員將立即採取移除該數位著作等補救措施。
    NCCU Institutional Repository is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff(nccur@nccu.edu.tw). We will remove the work from the repository and investigate your claim.
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback